WS #15089

The macro landscape has shifted sharply from geopolitical containment to monetary tightening and bond market stress. Fed Vice Chair Barr has signaled that further rate hikes are likely as GDP growth picks up and inflation risks have increased, directly contradicting the market's expectation of a pause. This hawkish pivot is corroborated by a plunge in US consumer confidence to its lowest level since 2014, creating a stagflationary dynamic that is driving 30-year Treasury yields to their highest levels since 2002. The bond market is now pricing in a higher neutral rate, likely fueled by AI-driven capital expenditure and persistent inflation, which exerts severe pressure on high-multiple growth stocks and rate-sensitive sectors. Geopolitically, the Strait of Hormuz situation shows signs of de-escalation as oil traffic has returned to 70% of pre-conflict levels, dampening the immediate energy supply crisis. However, the Trump administration's criticism of EU reserve releases and the administration's $15 billion steel complex plan in Iowa are creating new trade and industrial policy frictions. Meanwhile, the AI sector remains the primary driver of equity momentum, highlighted by the 'Super Intelligence Luncheon' where Trump flanked Jensen Huang and Elon Musk with major AI lab CEOs, and AMD's $8.2 billion acquisition of World Labs to bolster its robotics and AI capabilities. Notable divergences exist within the tech sector: while NVDA trades at record percentile valuations supported by AI capex, consumer sentiment weakness poses a headwind. In biotech, Xeris Biopharma is surging on acquisition interest from Lundbeck, and Iovance Biotherapeutics has rallied 33% on raised revenue outlooks. The market is currently balancing the bullish AI narrative against the bearish macro reality of rising yields and falling consumer confidence.